RSV vaccine uptake will start slower than shingles shot: GSK CEO

GSK says its RSV vaccine for older adults gives long-term protection

News - VaccineNation

GSK expects RSV vaccine uptake will be slower than shingles vaccine-CEO, 104.1 WIKY

GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year

RSV vaccine race heats up with highly effective GSK shot

RSV vaccine uptake will start slower than shingles shot: GSK CEO

GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year

GSK crushed Pfizer in first round of RSV vaccine showdown

News - VaccineNation

GSK's RSV vaccine bolsters bottom line, company raises full-year guidance